Markets & Regulations

(gilz/iStock via Getty Images Plus)

Weekly FDA COVID-19 updates and actions

By Jenni Spinner

The agency continues to offer advice to pharma industry professionals during the global public health crisis, and offer advice on developing solutions.

(April Thornberg/iStock via Getty Images Plus)

This week’s FDA COVID-19 news

By Jenni Spinner

The agency continues to offer advice for drug developers and other stakeholders, and to take action against companies that step out of line.

(Who_I_am/iStock via Getty Images Plus)

This week’s FDA COVID-19 updates

By Jenni Spinner

The US agency continues to issue advice, offer guidance and take action related to the virus behind the global pandemic.

(rudal30/iStock via Getty Images Plus)

FDA COVID-19 updates for the week

By Jenni Spinner

The federal agency continues to aid drug developers, trial teams and the public with advice and actions related to the virus behind the global pandemic.

(ChakisAtelier/iStock via Getty Images Plus)

Current FDA COVID-19 updates and actions

By Jenni Spinner

The agency continues to offer advice related to drug development and clinical research during the pandemic, and take action against those falling out of line.

(Nuthawut Somsuk/iStock via Getty Images Plus)

Newest FDA actions and alerts on COVID-19

By Jenni Spinner

The federal agency continues to monitor as the virus impacts the pharma and clinical trials industries, offering advice and taking action where necessary.

(elenabs/iStock via Getty Images Plus)

Latest FDA COVID-19 updates

By Jenni Spinner

The federal agency continues to offer advice and take actions related to COVID-19, impacting drug development, clinical trials and other activities.

(zubada/iStock via Getty Images Plus)

This week’s FDA COVID-19 updates

By Jenni Spinner

The agency continues to offer advice and take actions impacting the pharmaceutical and life-science industries during the pandemic.

(Image: Getty/gorodenkoff)

Avalere: FDA can impact COVID-era drug development

By Jenni Spinner

A representative of the life-sciences consulting firm outlines how the federal agency has reacted to the COVID-19 pandemic, and how it might advise the industry going forward.

(Image: Getty/zubada)

This week's FDA COVID-19 actions and advice

By Jenni Spinner

The federal agency continues to offer advice for healthcare and pharma industry professionals, and to take action against companies acting out of bounds.

(Image: Getty/ffrikretow)

Weekly FDA COVID-19 update

By Jenni Spinner

The agency continues to remain busy overseeing and approving potential treatments and tests for the virus behind the global pandemic.

(Image: Getty/metamorworks)

People on the Move: May 2020

By Jenni Spinner

This month’s new hires and promotions include executive appointments at Advarra, Eversana, Signant Health, Endpoint Clinical and other companies.

(Image: Getty/zubada)

This week’s FDA COVID-19 news

By Jenni Spinner

The agency continues to offer guidance about COVID-19 treatments and tests—and issue warnings to companies that fall out of line.

Follow us

Products

View more

Webinars